Study identifies enzymes needed to mend tissue damage after inflammation

June 14, 2012 by Anne Trafton, Massachusetts Institute of Technology
This micrograph shows a colorectal adenoma, a benign form of cancer that can turn malignant. Image: Wikipedia/Nephron

A major risk factor for colon cancer — the second leading cause of cancer death in the United States — is chronic inflammation of the colon. Nearly 10 percent of patients with inflammatory bowel disease (IBD) eventually develop colon cancer.

A new study from MIT demonstrates that this cancer arises from a specific type of DNA damage produced during inflammation. The researchers, led by Leona Samson, professor of biological engineering and biology, showed that mice that cannot this type of DNA damage are susceptible to colon cancer.

The team also identified three enzymes critical to repairing this damage. Previous studies have shown that humans produce widely varying amounts of one of the enzymes, so the findings offer a possible explanation for why some IBD patients are more likely to develop colon cancer, Samson says. Measuring these enzyme levels in a particular patient could help predict that patient’s risk of colon cancer.

“All other things being equal, if the same inflammatory response is present in the colon of different individuals, but they have differences in DNA-repair capability, they’re probably going to respond differently,” says Samson, who also a member of MIT’s Center for Environmental Health Sciences.

Jennifer Calvo, a research scientist in Samson’s lab, and Lisiane Meira, a former MIT scientist now at the University of Surrey, are lead authors of a paper on the new work appearing in the June 11 online edition of the Journal of Clinical Investigation.

Repair failure

During the chronic inflammation seen in conditions such as IBD (which includes Crohn’s disease and ulcerative colitis), immune cells release highly destructive chemicals known as reactive oxygen and nitrogen species. These chemicals are meant to kill bacteria and other invading pathogens, but if the chemicals linger too long, they can damage DNA and other molecules in healthy cells.

Four years ago, Samson’s lab showed that these reactive molecules produce a specific type of DNA damage that leads to colon cancer in mice. In that study, the researchers found that a DNA repair enzyme called AAG was necessary to repair this type of damage, known as etheno-base lesions. Mice lacking the AAG enzyme were much more susceptible to inflammation-induced colon cancer.

In the new study, funded by the National Institutes of Health, Samson and her colleagues looked at the effects of two additional DNA-repair enzymes. These enzymes, known as ALKBH2 and ALKBH3, were previously shown to be involved in repairing etheno-base lesions.

To induce colon inflammation in mice, researchers treat them with a chemical called dextran sodium sulfate (DSS), which destroys the mucosal lining of the intestines, allowing bacteria to reach the epithelial cells and provoke an inflammatory response. Following such inflammation, mice missing both ALKBH2 and ALKBH3 were much more susceptible to than normal mice; the results were even more dire among mice missing all three DNA repair enzymes.

After analyzing tissue samples, the researchers discovered that all of the mice had initially experienced similar extensive colon damage, but mice with at least one of the three DNA repair enzymes were able to repair most or all of the tissue damage. lacking all three enzymes couldn’t perform any tissue repair whatsoever.

Achieving DNA repair is especially critical in stem cells required to regenerate tissue. “Whatever cells are required for this tissue reconstruction are presumably being killed off because they can’t repair the DNA damage induced during inflammation,” Samson says.

The exact nature of the interactions between the three enzymes is unknown, but Samson speculates that AAG may first bind to the DNA lesions and then recruit ALKBH2 and ALKBH3 to help repair them.

Steven Lipkin, an associate professor of medicine at Weill Cornell Medical College, says the research “elegantly demonstrates” that distinct DNA-repair pathways are involved in repairing DNA damage caused by inflammation in the colon.

“This study gives insights that will help us to understand the precise mechanisms that cause inflammatory bowel disease-associated colorectal cancer, and will open the door to discovering better targeted chemopreventative agents,” says Lipkin, who was not involved in this study.

The MIT team is now looking into how varying levels of the AAG affect overall health, and is also planning to study how all three of these DNA-repair enzymes respond to induced by Helicobacter pylori infection, which can lead to stomach cancer.

Explore further: Study offers comprehensive look at chemical, genetic changes that occur as inflammation progresses to cancer

Related Stories

Study offers comprehensive look at chemical, genetic changes that occur as inflammation progresses to cancer

June 11, 2012
One of the biggest risk factors for liver, colon or stomach cancer is chronic inflammation of those organs, often caused by viral or bacterial infections. A new study from MIT offers the most comprehensive look yet at how ...

Common bacteria cause some colon tumors by altering peroxide-producing gene

November 5, 2011
Working with lab cultures and mice, Johns Hopkins scientists have found that a strain of the common gut pathogen Bacteroides fragilis causes colon inflammation and increases activity of a gene called spermine oxidase (SMO) ...

Scientists identify protein that improves DNA repair under stress

June 16, 2011
Cells in the human body are constantly being exposed to stress from environmental chemicals or errors in routine cellular processes. While stress can cause damage, it can also provide the stimulus for undoing the damage. ...

New study unravels mystery of a DNA repair process

March 14, 2012
(Medical Xpress) -- Scientists at the University of Sussex have uncovered the mechanism of a key process in DNA repair that helps prevent neurodegenerative diseases such as ataxia.

Recommended for you

Chronic inflammation causes loss of muscle mass during aging

January 12, 2018
People start losing muscle mass at the age of 40—about some 10 percent of the total muscle mass for each 10-year period, which may lead to fall-related injuries, slowing metabolism and reduced quality of life. Today, very ...

Breathing exercises help asthma patients with quality of life

December 13, 2017
A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught breathing ...

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.